SI-BONE, Inc. - Common Stock (SIBN)
19.84
+0.96 (5.08%)
NASDAQ · Last Trade: May 16th, 2:06 PM EDT
Detailed Quote
Previous Close | 18.88 |
---|---|
Open | 18.90 |
Bid | 19.81 |
Ask | 19.85 |
Day's Range | 18.73 - 19.84 |
52 Week Range | 11.70 - 19.35 |
Volume | 422,156 |
Market Cap | 660.10M |
PE Ratio (TTM) | -31.00 |
EPS (TTM) | -0.6 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 505,688 |
Chart
About SI-BONE, Inc. - Common Stock (SIBN)
Si-Bone Inc is a medical technology company focused on developing and commercializing innovative solutions for the treatment of musculoskeletal conditions, particularly those affecting the sacroiliac joint. The company specializes in minimally invasive surgical techniques and instruments that aim to alleviate pain and restore function for patients suffering from various spinal disorders. By leveraging advanced technology and evidence-based practices, Si-Bone seeks to improve patient outcomes while enhancing the efficiency of surgical procedures in the orthopedic field. Read More
News & Press Releases
Four companies experienced significant short-term rallies following better-than-expected earnings; can they maintain momentum going forward?
Via MarketBeat · May 14, 2025
Via Benzinga · May 5, 2025
Via Benzinga · March 14, 2025
Via Benzinga · March 14, 2025

Via Benzinga · January 16, 2025

Via Benzinga · January 16, 2025

Via Benzinga · January 13, 2025

Via Benzinga · December 18, 2024

Via Benzinga · August 6, 2024

SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via InvestorPlace · July 31, 2024

SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

Via Benzinga · May 6, 2024

Via Benzinga · March 28, 2024

Via Benzinga · February 27, 2024